Product Information
Applications
Biological Information
Primary Targetkappa opioid receptor
Purity≥98% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
Toxicity Standard Handling
Storage -20°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications

Documentation

nor-Binaltorphimine Dihydrochloride - CAS 105618-26-6 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

References

Reference overview
Kishioka, S., et al. 2013. Neurosci. Letters. In press.
Valdez, G., et al. 2012. Pharma. Biochem. and Behavior. 102, 44.
Takemori AE et al. 1988. J. Pharmacol. Exp. Ther. 246, 255.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision13-March-2017 JSW
SynonymsNorbinaltorphimine, nor-BNI, κ Opioid Receptor Antagonist, nor-Binaltorphimine
DescriptionA potent antagonist highly selective for κ opioid receptor with no effect on µ- or &delta- opioid receptors. Widely used in studies related to pain, addition, anxiety, depression, and sleep.
FormWhite to off-white solid
CAS number105618-26-6
Chemical formulaC₄₀H₄₃N₃O₆·2HCl
Structure formulaStructure formula
Purity≥98% by HPLC
SolubilityH₂O (50 mM)
Storage -20°C
Protect from light
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Standard Handling
ReferencesKishioka, S., et al. 2013. Neurosci. Letters. In press.
Valdez, G., et al. 2012. Pharma. Biochem. and Behavior. 102, 44.
Takemori AE et al. 1988. J. Pharmacol. Exp. Ther. 246, 255.

Related Products & Applications

Categories

Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Neurochemicals > Agonists